Accelerate Diagnostics Inc EV/EBIT
Was ist das EV/EBIT von Accelerate Diagnostics Inc?
EV/EBIT von Accelerate Diagnostics Inc ist N/A
Was ist die Definition von EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Accelerate Diagnostics Inc
Was macht Accelerate Diagnostics Inc?
accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.
Unternehmen mit ev/ebit ähnlich Accelerate Diagnostics Inc
- Centogene NV hat EV/EBIT von N/A
- Delek US Inc hat EV/EBIT von N/A
- Freeport Resources hat EV/EBIT von N/A
- AMMO hat EV/EBIT von N/A
- AMMO hat EV/EBIT von N/A
- Ultragenyx Pharmaceutical hat EV/EBIT von N/A
- Accelerate Diagnostics Inc hat EV/EBIT von N/A
- Eros International Plc hat EV/EBIT von N/A
- Deveron UAS hat EV/EBIT von N/A
- HT Media hat EV/EBIT von N/A
- Aguila American Gold hat EV/EBIT von N/A
- Sri Adhikari Brothers Television Network hat EV/EBIT von N/A
- Zicom Electronic Security Systems hat EV/EBIT von N/A